Decision Diagnostics Corp. (OTCBB: DECN) Soars After Favorable Court Ruling
Investors who stayed with Decision Diagnostics Corp. (OTCBB:DECN) must have congratulated themselves for making the right decision. On November 4 the U.S. Federal Circuit Court of Appeals sustained DECN‘s appeal, reversed a ruling made by a lower court and more importantly ruled that the Johnson & Johnson Lifescan patent rights were subject to patent exhaustion thus removing the major hurdle that stood in DECN‘s path.
- $41 thousand cash
- $4.6 million total current assets
- $4.1 million total current liabilities
- $304 thousand revenues
- $771 thousand net loss
They have a positive working capital but the amount of the net loss is still considerable. On October 29 the company was able to significantly improve its cash reserves by entering into a $12.5 million revolving credit facility with Alpha Credit Resources, LLC, a division of Platinum Credit Management LP. Unlike the usual credit deals we see in the pennystock world this credit will feature no equity conversion and thus spare investors from suffering any dilution.
Last Friday Sovereign Lithium Inc (OTCMKTS:SLCO) got suspended by the SEC just a day after a paper mailer touting the company was revealed. SLCO is no stranger to paid pumps, in fact, under their previous name and ticker Great American Energy Inc. (SRBL) they were among the most heavily pumped tickers for 2013. On the other hand the pump for Pan Global Corp. (OTCMKTS:PGLO) is still going on with new email alerts sent over the weekend. In early trading today the stock is 22% up trading for $0.7 per share.